Caribou Biosciences (CRBU) News Today → Crypto Pioneer Says: “The last crypto bull market has begun.” (From InvestorPlace) (Ad) Free CRBU Stock Alerts $3.71 +0.17 (+4.80%) (As of 05/13/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 13 at 3:34 PM | marketbeat.comHC Wainwright Reaffirms "Buy" Rating for Caribou Biosciences (NASDAQ:CRBU)HC Wainwright restated a "buy" rating and set a $24.00 price target on shares of Caribou Biosciences in a report on Monday.May 13 at 2:38 AM | markets.businessinsider.comAnalysts’ Opinions Are Mixed on These Healthcare Stocks: Caribou Biosciences (CRBU) and Mettler-Toledo (MTD)May 12 at 4:00 PM | investorplace.com3 Underappreciated Stocks That Could 10x in 10 YearsMay 11 at 2:29 AM | americanbankingnews.comBrookline Capital Management Analysts Lower Earnings Estimates for Caribou Biosciences, Inc. (NASDAQ:CRBU)May 11 at 2:29 AM | americanbankingnews.comQ2 2024 Earnings Estimate for Caribou Biosciences, Inc. Issued By Leerink Partnrs (NASDAQ:CRBU)May 10, 2024 | markets.businessinsider.comBuy Rating Affirmed: Caribou Biosciences’ Advancing Pipeline and Strong Financials Drive Analyst ConfidenceMay 10, 2024 | marketbeat.comQ2 2024 Earnings Forecast for Caribou Biosciences, Inc. Issued By Brookline Capital Management (NASDAQ:CRBU)Caribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) - Equities researchers at Brookline Capital Management reduced their Q2 2024 EPS estimates for shares of Caribou Biosciences in a research note issued on Tuesday, May 7th. Brookline Capital Management analyst L. Cann now forecasts that the comMay 9, 2024 | finance.yahoo.comCaribou Biosciences, Inc. (NASDAQ:CRBU) Analysts Are Cutting Their Estimates: Here's What You Need To KnowMay 7, 2024 | finance.yahoo.comCaribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business UpdateMay 7, 2024 | finance.yahoo.comCaribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business UpdateApril 24, 2024 | globenewswire.comCaribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingApril 18, 2024 | seekingalpha.comCaribou Biosciences: 2 Clinical Data Updates In 2024 Could Bring ValueApril 15, 2024 | globenewswire.comCaribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)April 15, 2024 | marketbeat.comVanguard Group Inc. Increases Stock Holdings in Caribou Biosciences, Inc. (NASDAQ:CRBU)Vanguard Group Inc. grew its holdings in shares of Caribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) by 49.3% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,822,151 shares of the company's stock after purchasing an addApril 8, 2024 | markets.businessinsider.comBuy Rating Affirmed: Caribou Biosciences’ Promising Trials and Strategic Market PositioningApril 5, 2024 | msn.comKura Sushi Posts Upbeat Sales, Joins Caribou Biosciences, Krispy Kreme And Other Big Stocks Moving Higher In Friday's Pre-Market SessionApril 5, 2024 | finanznachrichten.deCaribou Biosciences, Inc.: Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in LupusApril 4, 2024 | globenewswire.comCaribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in LupusApril 2, 2024 | marketbeat.comShort Interest in Caribou Biosciences, Inc. (NASDAQ:CRBU) Increases By 7.2%Caribou Biosciences, Inc. (NASDAQ:CRBU - Get Free Report) was the target of a large increase in short interest in March. As of March 15th, there was short interest totalling 10,070,000 shares, an increase of 7.2% from the February 29th total of 9,390,000 shares. Based on an average daily volume of 1,650,000 shares, the short-interest ratio is currently 6.1 days. Approximately 12.7% of the company's stock are short sold.April 1, 2024 | finance.yahoo.comWith 65% institutional ownership, Caribou Biosciences, Inc. (NASDAQ:CRBU) is a favorite amongst the big gunsMarch 29, 2024 | marketbeat.comAssenagon Asset Management S.A. Has $12.94 Million Stock Holdings in Caribou Biosciences, Inc. (NASDAQ:CRBU)Assenagon Asset Management S.A. lowered its position in Caribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) by 14.7% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,258,539 shares of the company's stock after sellingMarch 25, 2024 | marketbeat.comCaribou Biosciences (NASDAQ:CRBU) Stock Price Up 6.5%Caribou Biosciences (NASDAQ:CRBU) Shares Up 6.5%March 21, 2024 | marketbeat.comQ1 2024 EPS Estimates for Caribou Biosciences, Inc. (NASDAQ:CRBU) Lifted by HC WainwrightCaribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) - HC Wainwright increased their Q1 2024 earnings per share estimates for Caribou Biosciences in a research note issued on Tuesday, March 19th. HC Wainwright analyst R. Burns now expects that the company will post earnings of ($0.39) per shareMarch 19, 2024 | marketbeat.comCaribou Biosciences (NASDAQ:CRBU) Shares Gap Up After Analyst UpgradeCaribou Biosciences (NASDAQ:CRBU) Shares Gap Up on Analyst UpgradeMarch 19, 2024 | marketbeat.comCaribou Biosciences (NASDAQ:CRBU) Price Target Increased to $24.00 by Analysts at HC WainwrightHC Wainwright lifted their price target on shares of Caribou Biosciences from $23.00 to $24.00 and gave the company a "buy" rating in a research note on Tuesday.March 18, 2024 | marketbeat.comFY2024 EPS Estimates for Caribou Biosciences, Inc. Decreased by Cantor Fitzgerald (NASDAQ:CRBU)Caribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) - Research analysts at Cantor Fitzgerald dropped their FY2024 earnings per share (EPS) estimates for shares of Caribou Biosciences in a research note issued to investors on Wednesday, March 13th. Cantor Fitzgerald analyst R. Bienkowski now expMarch 15, 2024 | marketbeat.comCaribou Biosciences, Inc. to Post Q1 2024 Earnings of ($0.44) Per Share, Leerink Partnrs Forecasts (NASDAQ:CRBU)Caribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) - Research analysts at Leerink Partnrs reduced their Q1 2024 earnings per share (EPS) estimates for Caribou Biosciences in a report released on Tuesday, March 12th. Leerink Partnrs analyst M. Foroohar now forecasts that the company will earn (March 14, 2024 | finance.yahoo.comCRBU Oct 2024 5.000 putMarch 14, 2024 | msn.comCaribou Biosciences (NASDAQ:CRBU): Recent Price Volatility May Offer Investors an Entry PointMarch 14, 2024 | marketbeat.comQ1 2024 Earnings Estimate for Caribou Biosciences, Inc. Issued By Brookline Capital Management (NASDAQ:CRBU)Caribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) - Equities researchers at Brookline Capital Management reduced their Q1 2024 earnings estimates for Caribou Biosciences in a research report issued on Monday, March 11th. Brookline Capital Management analyst L. Cann now expects that the companMarch 13, 2024 | markets.businessinsider.comOptimistic Outlook for Caribou Biosciences with a Buy Rating and $20 Price TargetMarch 13, 2024 | marketbeat.comCaribou Biosciences, Inc. (NASDAQ:CRBU) Expected to Earn FY2028 Earnings of ($0.72) Per ShareCaribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) - Stock analysts at Brookline Capital Management issued their FY2028 earnings per share estimates for shares of Caribou Biosciences in a research note issued to investors on Monday, March 11th. Brookline Capital Management analyst L. Cann foreMarch 12, 2024 | marketwatch.comCaribou Biosciences Shares Fall on Wall Street MissMarch 12, 2024 | fool.comWhy Caribou Biosciences Stock Is Crashing TodayMarch 12, 2024 | marketbeat.comCaribou Biosciences (NASDAQ:CRBU) Stock Price Down 18.4%Caribou Biosciences (NASDAQ:CRBU) Stock Price Down 18.4%March 12, 2024 | finanznachrichten.deCaribou Biosciences, Inc.: Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateMarch 11, 2024 | msn.comCaribou Bioscience GAAP EPS of -$0.39 in-line, revenue of $3.56M misses by $1.05MMarch 11, 2024 | markets.businessinsider.comCaribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateMarch 11, 2024 | globenewswire.comCaribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateMarch 6, 2024 | finance.yahoo.comCaribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual MeetingMarch 5, 2024 | marketbeat.com165,192 Shares in Caribou Biosciences, Inc. (NASDAQ:CRBU) Acquired by Laurion Capital Management LPLaurion Capital Management LP bought a new position in shares of Caribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund bought 165,192 shares of the company's stock, valued at approximately $790,000. LaurioMarch 3, 2024 | marketbeat.comAlkeon Capital Management LLC Has $7.86 Million Stock Position in Caribou Biosciences, Inc. (NASDAQ:CRBU)Alkeon Capital Management LLC lifted its position in shares of Caribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) by 21.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,644,863 shares of the companyMarch 2, 2024 | ca.finance.yahoo.comCRBU Oct 2024 2.500 callMarch 1, 2024 | marketbeat.comProfund Advisors LLC Takes $406,000 Position in Caribou Biosciences, Inc. (NASDAQ:CRBU)Profund Advisors LLC bought a new position in shares of Caribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 84,899 shares of the company's stock, valued at approximFebruary 29, 2024 | marketbeat.comCitigroup Inc. Acquires 194,816 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU)Citigroup Inc. boosted its holdings in Caribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) by 739.3% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 221,166 shares of the company's stock after buying anFebruary 24, 2024 | finance.yahoo.comSteven Cohen's Point72 Adds Caribou Biosciences Inc to Its PortfolioFebruary 23, 2024 | finance.yahoo.comCRBU Mar 2024 7.500 putFebruary 23, 2024 | benzinga.comCaribou Biosciences Stock (NASDAQ:CRBU), Short Interest ReportFebruary 22, 2024 | marketbeat.comRafferty Asset Management LLC Purchases Shares of 507,400 Caribou Biosciences, Inc. (NASDAQ:CRBU)Rafferty Asset Management LLC acquired a new stake in shares of Caribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 507,400 shares of the companFebruary 19, 2024 | marketbeat.comBarclays PLC Acquires 236,020 Shares of Caribou Biosciences, Inc. (NASDAQ:CRBU)Barclays PLC raised its stake in shares of Caribou Biosciences, Inc. (NASDAQ:CRBU - Free Report) by 1,296.0% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 254,231 shares of the company's stock after acquiring an additional 236,020 shares during the period. Get Caribou Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CRBU and its competitors with MarketBeat's FREE daily newsletter. Email Address America could fall from this event (Ad)America’s “Internal Enemies” Exposed New documentary exposes a hidden election plan in Washington D.C. that, if successful, could be more financially and culturally devastating than the dot-com blowup of 2000, the 2008 financial crisis, or the COVID crash. Click here to see how you can protect yourself today. CRBU Media Mentions By Week CRBU Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CRBU News Sentiment▼-0.120.57▲Average Medical News Sentiment CRBU News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CRBU Articles This Week▼212▲CRBU Articles Average Week Get Caribou Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for CRBU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Jasper Therapeutics News Today MeiraGTx News Today SOPHiA GENETICS News Today Anavex Life Sciences News Today Tenaya Therapeutics News Today Aura Biosciences News Today Invivyd News Today Black Diamond Therapeutics News Today Monte Rosa Therapeutics News Today Poseida Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CRBU) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsThis 1 Biotech Stock has been shocking the marketsHuge AlertsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceCharles Payne Demystifies OptionsUnstoppable Prosperity Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Caribou Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
